Target intelligence / Profile preview

DNA topoisomerase II–DNA complex (Top2–DNA complex (or TOP2cc for "topoisomerase II cleavage complex"))

Target
Top2–DNA complex (or TOP2cc for "topoisomerase II cleavage complex")
Molecular classification
Enzyme (specifically, type II DNA topoisomerase), Enzyme-DNA covalent intermediate, Other: transient protein-DNA adduct
01

Overview

The **Topoisomerase II–DNA complex**, also known as the "cleavage complex" or "TOP2cc," is a transient covalent intermediate formed when type II DNA topoisomerases cleave both strands of duplex DNA to resolve supercoiling, catenanes, and other topological problems during essential cellular processes such as replication, transcription, and chromosome segregation. The enzyme forms a reversible phosphotyrosine bond with each broken strand; under normal conditions this break is quickly resealed. However, anticancer agents known as "topo-II poisons" stabilize this otherwise fleeting state by preventing religation. This leads to persistent double-strand breaks that trigger cell death—an effect exploited therapeutically against cancer but also associated with significant risks including secondary cancers and cardiotoxicity. The structure-function relationship within these ternary complexes has been elucidated at high resolution; key domains involved include the winged helix domain (WHD) containing the active site tyrosine responsible for catalysis and metal ion coordination by the TOPRIM domain critical for breakage/religation chemistry. The clinical importance stems from both their central role in cell proliferation control—and their vulnerability to pharmacologic intervention—making them validated targets across multiple chemotherapeutic regimens.[1][4][5][6]

Other names
Topoisomerase II–DNA cleavage complexTOP2ccDNA topoisomerase II covalent intermediateType IIA topoisomerase–DNA complex
02

Mechanism of action

Drugs targeting this molecule act primarily as **topoisomerase poisons**, which: - Stabilize the transient covalent Top2–DNA cleavage complexes, preventing religation of double-stranded breaks.[5][6][3] - Lead to accumulation of double-strand breaks, blocking replication/transcription and triggering apoptosis in rapidly dividing cells.[5][6] Some drugs are **catalytic inhibitors**, which: - Inhibit the catalytic activity without stabilizing the cleavage complex or causing direct DNA damage.[5]

03

Biological functions

Regulation of DNA topology (supercoiling, catenation/decatenation)[1][8]Resolution of DNA tangles and supercoils during replication and transcription[1][8]Chromosome segregation[8]Induction and repair of double-strand breaks in DNA[2][4]
04

Disease associations

Cancer (therapeutic target in chemotherapy)[5][6][3]Secondary malignancies due to therapy-induced genome instability[6]
05

Safety considerations

Notable safety concerns include:Risk of secondary malignancies such as therapy-related acute myeloid leukemia due to off-target genome instability from persistent Top2-mediated breaks.[6]Cardiotoxicity, especially with anthracycline-based therapies like doxorubicin.[6]Resistance mechanisms can develop via altered expression/mutation in Top2 isoforms or enhanced repair/removal pathways for trapped complexes.
06

Interacting drugs

Etoposide[2][3][5]

5 more in the full profile.

07

Biomarkers

There are no universally established biomarkers specific for patient selection based on Top2–DNA complexes. However:Expression levels of TOP2A or TOP2B genes/proteins may be used as surrogate markers for sensitivity to topoisomerase poisons.Accumulation of γH2AX foci can serve as a marker for drug-induced double-strand breaks.

Beyond the preview

Go deeper on DNA topoisomerase II–DNA complex (Top2–DNA complex (or TOP2cc for "topoisomerase II cleavage complex")).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA topoisomerase II–DNA complex (Top2–DNA complex (or TOP2cc for "topoisomerase II cleavage complex")).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call